Benjamin Eldridge

Ben Eldridge co-founded Nutcracker Therapeutics, Inc. and serves as its Chief Technology Officer. As Nutcracker’s systems architect, Ben leads the development of a device-based platform for large scale synthesis of nucleic acids.